Investing

Noble Mineral Closes its Non-Brokered Private Placement and Extends Warrants

November 21, 2025
Investing

Joe Cavatoni: Gold’s Key Driver Now, Plus 2026 Catalysts to Watch

November 21, 2025
Investing

Skyharbour Engages Emerging Markets Consulting LLC for Marketing Contract

November 21, 2025
Investing

Heliostar Presents Third Quarter 2025 Financial Results

November 21, 2025
Investing

Crypto Market Update: Bitcoin Price Slide Continues, Kraken Files for IPO

November 21, 2025
Politics

Schumer, Jeffries accuse Trump of calling for ‘execution of elected officials’

November 21, 2025
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Crypto Market Update: Bitcoin, Altcoins Continue Week-long Decline

October 20, 2025

Reserve and Resource Update

May 20, 2025

Crypto Market Recap: Swiss Central Bank Dismisses Bitcoin...

April 26, 2025

5 Small-cap Biotech ETFs to Watch in 2025

October 8, 2025

Ian Rodger Appointed Managing Director

July 1, 2025

Top 5 Palladium and Platinum Countries by Production

September 25, 2025

Resignation of Managing Director/CEO

July 21, 2025

Crypto Market Update: Bitcoin ETF Inflows Hit US$2.3...

September 16, 2025

Teck Greenlights Highland Valley Expansion After Beating Q2...

July 26, 2025

Editor’s Picks: Silver Price Hits 13 Year High,...

June 22, 2025